MedTrace Logo

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

NCT07216170 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-03-27

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of the SOFIA Flow 88 Aspiration Catheter for treatment of acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

SOFIA Flow 88 Aspiration Catheter

The investigational device is the SOFIA Flow 88 Aspiration Catheter with the MV Flow Aspiration Pump and MicroVention Tubing Kit and is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 segment) within 8 hours of symptom onset.

Sponsors & Collaborators

  • Bright Research Partners

    collaborator INDUSTRY

  • Microvention-Terumo, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Hill, MD, MSc · University of Calgary & Foothills Medical Centre

  • Charles Matouk, MD · Yale University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07216170 on ClinicalTrials.gov